Career Development
职业发展
基本信息
- 批准号:9333239
- 负责人:
- 金额:$ 4.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-01 至
- 项目状态:未结题
- 来源:
- 关键词:AchievementAdvisory CommitteesAdvocacyAnimal ModelApplications GrantsAreaBasic ScienceBiometryBiostatistics CoreClinicClinical SciencesDataDevelopmentDiagnosisDisabled PersonsDiseaseEligibility DeterminationEnsureEnvironmentExtramural ActivitiesFacultyFundingFutureGoalsGrantIndividualK-Series Research Career ProgramsLeadershipMalignant neoplasm of ovaryManuscriptsMedicineMentorsMentorshipMinorityMonitorOvarianPoliciesPopulation SciencesPreventionProceduresProcessProductivityProgram DevelopmentPublishingRecruitment ActivityReportingResearchResearch PersonnelResourcesScientistSystemTranslational ResearchWomanWorkanticancer researchbasecandidate selectioncareercareer developmentexpectationimprovedinterestmeetingsmultidisciplinaryprogramsskillssuccesstranslational scientist
项目摘要
ABSTRACT – Career Development Program
The purpose of the Mayo Clinic SPORE in Ovarian Cancer is to stimulate, organize and facilitate rigorous
translational research that will meaningfully reduce the burden of ovarian cancer. A critical part of this process
is to increase the quality and depth of the translational investigator base in ovarian cancer. During the first five
years of funding, four individuals received Career Development Awards and were supported with 1-2 years of
funding, mentoring teams, and full access to SPORE resources. Our awardees have been highly successful,
with 14 manuscripts published and an additional 2 under review, all receiving subsequent funding and two
(Paul Haluska and Matthew Block) advancing to co-leadership of projects in this renewal application;
additionally, Dr. Haluska is the Director of the Animal Models Core. All awardees relied upon the
Biospecimens and Biostatistics Cores to develop their research programs; Dr. Haluska also partnered with the
Animal Models Core. The ultimate objectives of the Career Development Program (CDP) continue to be the
identification and mentoring of new and developing investigators in ovarian cancer who demonstrate clear
potential to become independent translational researchers as well as attracting established scientists who wish
to refocus on ovarian cancer. The CDP provides up to $100,000 for one year of support ($50,000 from
SPORE funds and a matching $50,000 from Mayo Clinic); a second year is possible based on progress and
continued translational trajectory. Emphasis is placed on attracting highly qualified individuals
underrepresented in medicine, including women and minorities. Identifying and selecting CDP awardees is
accomplished through a rigorous review process, followed by intense mentoring, integration into ongoing
SPORE activities and close oversight of the individual's progress. In addition to a primary mentor, awardees
have complementary mentors in clinical, basic or population sciences necessary to ensure development of a
translational research career. This capitalizes on numerous strengths present within the Mayo environment.
The CDP reports to the Executive Committee of the Mayo Clinic Ovarian Cancer SPORE. During the next
funding period, the Ovarian SPORE will continue to maintain: (1) a stringent candidate selection system; (2)
comprehensive trainee guidance by a primary mentor; (3) support through a scientific mentoring group (the
Individual Trainee Mentorship Committee) comprised of investigators with expertise in each trainee`s area of
interest; and (4) full integration into the SPORE, including access to all scientific Cores. Mayo Clinic provides
an exceptional environment for developing careers in translational research in ovarian cancer. The CDP
allows us to identify, mentor, and support young investigators who will become future leaders in ovarian cancer
research.
摘要-职业发展计划
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELLEN L. GOODE其他文献
ELLEN L. GOODE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELLEN L. GOODE', 18)}}的其他基金
Relating Molecular Subgroups of Endometriosis-Associated Ovarian Cancers to Survival and Risk
子宫内膜异位症相关卵巢癌的分子亚群与生存和风险的关系
- 批准号:
10117829 - 财政年份:2021
- 资助金额:
$ 4.98万 - 项目类别:
Relating Molecular Subgroups of Endometriosis-Associated Ovarian Cancers to Survival and Risk
子宫内膜异位症相关卵巢癌的分子亚群与生存和风险的关系
- 批准号:
10328566 - 财政年份:2021
- 资助金额:
$ 4.98万 - 项目类别:
Relating Molecular Subgroups of Endometriosis-Associated Ovarian Cancers to Survival and Risk
子宫内膜异位症相关卵巢癌的分子亚群与生存和风险的关系
- 批准号:
10534755 - 财政年份:2021
- 资助金额:
$ 4.98万 - 项目类别:
Epidemiology and Genomics of Ovarian Clear Cell Carcinoma
卵巢透明细胞癌的流行病学和基因组学
- 批准号:
9597497 - 财政年份:2018
- 资助金额:
$ 4.98万 - 项目类别:
Epidemiology and Genomics of Ovarian Clear Cell Carcinoma
卵巢透明细胞癌的流行病学和基因组学
- 批准号:
9753165 - 财政年份:2018
- 资助金额:
$ 4.98万 - 项目类别:
Genetic Variation in the NF-kappaB Pathway and Ovarian Cancer Etiology
NF-kappaB 通路的遗传变异与卵巢癌病因学
- 批准号:
8291440 - 财政年份:2007
- 资助金额:
$ 4.98万 - 项目类别:
Genetic Variation in the NF-kappaB Pathway and Ovarian Cancer Etiology
NF-kappaB 通路的遗传变异与卵巢癌病因学
- 批准号:
8137048 - 财政年份:2007
- 资助金额:
$ 4.98万 - 项目类别:
相似海外基金
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
- 批准号:
0451289 - 财政年份:2005
- 资助金额:
$ 4.98万 - 项目类别:
Standard Grant














{{item.name}}会员




